West Pharma (WST) Tops Q2 EPS by 17c, Revenues Beat; Raises FY19 EPS/Revenue Guidance

July 25, 2019 6:08 AM

West Pharma (NYSE: WST) reported Q2 EPS of $0.89, $0.17 better than the analyst estimate of $0.72. Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found